Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors

[1]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices. , 1986, The Journal of pharmacology and experimental therapeutics.

[2]  R. Roth,et al.  Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. , 1986, The Journal of pharmacology and experimental therapeutics.

[3]  J. C. Stoof,et al.  Stimulation of D-2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine. , 1985, European journal of pharmacology.

[4]  R. Roth.  CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Function a , 1984, Annals of the New York Academy of Sciences.

[5]  R. Roth,et al.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons , 1984, Neuroscience.

[6]  F. J. White,et al.  A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. , 1984, Life sciences.

[7]  G. Gessa,et al.  Evidence for dopamine autoreceptors in mesocortical dopamine neurons , 1984, Brain Research.

[8]  B. Bunney,et al.  Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: A putative selective dop amine autoreceptor agonist , 1983, Neuropharmacology.

[9]  R. Roth,et al.  Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices. , 1983, European journal of pharmacology.

[10]  L. Cubeddu,et al.  Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum. , 1983, The Journal of pharmacology and experimental therapeutics.

[11]  M. Briley,et al.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. , 1983, European journal of pharmacology.

[12]  K. Fuxe,et al.  Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain. , 1982, Acta physiologica Scandinavica.

[13]  L. Cubeddu,et al.  Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors. , 1982, The Journal of pharmacology and experimental therapeutics.

[14]  J. C. Stoof,et al.  Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. , 1982, European journal of pharmacology.

[15]  L. Cubeddu,et al.  Rate and Duration of Stimulation Determine Presynaptic Effects of Haloperidol on Dopaminergic Neurons , 1982, Journal of neurochemistry.

[16]  R. Dantzer,et al.  Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. , 1982, Life sciences.

[17]  K. Starke,et al.  Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different? , 1982, Neuroscience.

[18]  R. Roth,et al.  Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones , 1982, Nature.

[19]  R. Roth,et al.  Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems. , 1981, Brain research.

[20]  L. Cubeddu,et al.  Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons. , 1980, The Journal of pharmacology and experimental therapeutics.

[21]  P. Jenner,et al.  Specific binding of [3H]sulpiride to rat striatal preparations , 1979, The Journal of pharmacy and pharmacology.

[22]  L. Cubeddu,et al.  Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid. , 1979, The Journal of pharmacology and experimental therapeutics.

[23]  P. Spano,et al.  Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. , 1978, Life sciences.

[24]  B. Scatton.  Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. , 1977, European journal of pharmacology.

[25]  T. Westfall,et al.  The effect of cyclic nucleotides on the release of 3H-dopamine from rat striatal slices. , 1976, The Journal of pharmacology and experimental therapeutics.

[26]  J. Glowinski,et al.  Selective activation of the mesocortical DA system by stress , 1976, Nature.

[27]  R. Roth,et al.  Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis. , 1976, Molecular pharmacology.

[28]  R. Roth,et al.  Acceleration of noradrenaline biosynthesis in the guinea‐pig vas deferens by potassium , 1970, British journal of pharmacology.

[29]  Joachim F. R. König,et al.  The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem , 1986 .

[30]  S. Snyder,et al.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. , 1971, Molecular pharmacology.